Nathalie Ledee/LinkedIn
Sep 29, 2025, 11:50
Nathalie Ledee Highlights Emerging Insights from ESHRE 2025
Nathalie Ledee, Obstetrician Gynecologist and PhD, CEO at MatriceLab, shared a post on LinkedIn:
“It was a great pleasure to spend a whole day immersed in the exciting world of reproductive immunology at this wonderful, huge ESHRE2025 congress. It became clear that immunosuppressive therapies cannot be prescribed indiscriminately. Precision care requires a diagnosis. Another good news is that the concept that endometrial immune equilibrium may help weak embryos (while not being necessary for top-quality ones) is now emerging. Further studies will reveal more about this crucial issue.”
-
Oct 11, 2025, 06:44The Global IVF Market Is Set to Reach $65B by 2032 – Meddilink
-
Dec 16, 2025, 15:03Always a Great Pleasure Returning to St. Jude Children’s Research Hospital – Gevorg Tamamyan
-
Dec 16, 2025, 14:45Chemical Pollution’s Impact on Male Reproductive Health – Cesar Fertility
-
Dec 16, 2025, 14:27Discover This Month’s Must-Read Articles – Fertility and Sterility
-
Dec 16, 2025, 13:20New Diagnostic Tools for Infertility Explored in Latest Review – Reproductive BioMedicine Online
-
Dec 15, 2025, 15:33Severe Postpartum Hemorrhage: Advances in Care Techniques – AGOF Asso Gynéco Obs en Formation
-
Dec 15, 2025, 15:27Silvia Alvarez: Key Findings on Egg Freezing Impact
-
Dec 14, 2025, 16:45Navigating Women’s Health Across Life Stages at SIGO – AOGOI
-
Dec 14, 2025, 16:38Steven Palter: The Role of Nutrition in Managing Infertility Explored
-
Dec 14, 2025, 16:19Impact of Preconception Metabolic Health on Fertility – Carrot